ALUMNI

1966

Don Nicholson (PGF, ophthalmology, 1971–72; PGF, neurology, 2000–02; PGF, 2007–10; faculty, 2010) recently published My Dementia Defense. It is written from the perspective of an experienced Alzheimer's caregiver and retired physician who is diagnosed with Alzheimer's disease at age 74. Writing the book became Nicholson’s defense against the progression of dementia.

Thomas J. Vander Salm (HS, surgery, 1966–69), a retired cardiac surgeon who has lived in New England for most of his life, recently published his first novel, Maiijke, about an infectiously likeable, curious and rambunctious Dutch farmer’s daughter.

1969

Joseph T. Coyle (HS, pediatrics, 1969–70; HS, psychiatry, 1973–76; faculty, 1980–91), the emeritus Eben S. Draper Chair of Psychiatry and Neuroscience at Harvard Medical School and past chairman of the Consolidated Academic Department of Psychiatry at Harvard, was honored by the commissioning of his portrait. Painted by Jason Patterson, it was unveiled on Feb. 29 and will be displayed in the main corridor of the administration building of McLean Hospital.

Steven Lehrer (A&S ’66) presented to the Harvard Neurology Department in June.

1977

Mark R. Katlic has retired from his position as chair of the department of surgery at LifeBridge Health System after 40 years as a thoracic surgeon. He currently lives on a farm in Baltimore County and writes novels. His medical thriller, Thorax, was just published.

1991

William Marks is the co-founder, general partner and chief medical officer at Nexus NeuroTech Ventures, an investment firm that supports the development of technology that aids in the diagnosis and management of brain disorders. The firm recently helped lead a $21.5 million Series B financing round for EarliTec Diagnostics, a medical device company focused on diagnostic and therapeutic solutions for children with autism and early childhood vulnerabilities.

1995

Ethan Weiss (HS, medicine, 1996–98) is co-founder and chief scientific officer at Marea Therapeutics. The clinical-stage biotechnology company incubated by Third Rock Ventures aims to develop a new generation of medicines for cardiometabolic diseases. Formally launched in June 2024, Marea Therapeutics has $190 million in venture funding.

Marcela del Carmen (HS, gynecology and obstetrics, 1995–99) was named president of Massachusetts General Hospital in March. She also serves as president of Massachusetts General Physicians Organization and executive vice president of Mass General Brigham. 

2003

Sean Moore (M.D., M.S.), a board-certified pediatrician and pediatric gastroenterologist, has been named the Mitchell Cohen Chair and Division Director of Gastroenterology, Hepatology and Nutrition at Cincinnati Children’s. He returned to Cincinnati Children’s from the University of Virginia, where he served as professor of pediatrics and chief of the Division of Pediatric Gastroenterology, Hepatology and Nutrition since 2020.

2005

Steven S. Chang, M.D. (A&S ’01; HS, Otolaryngology, 2005–12) is chair of the Department of Otolaryngology – Head & Neck Surgery for Henry Ford Health. Previously, he served as the department’s vice chair, director of Henry Ford’s Cancer Head and Neck Cancer Program, and director of the Center for Patient-Reported Outcome Measures. Chang and Mark P. Eid (Med ’06) started Acts Financial Advisors to offer wealth management, tax strategy and personal financial advising services to fellow physicians and business owners. The company recently surpassed $100 million in assets under management.

FORMER FACULTY, FELLOWS & RESIDENTS/HOUSE STAFF

David B. Allison (fellow, 1990–91) was presented with the inaugural Hofstra College of Liberal Arts and Sciences Alumni Spotlight Award, which recognizes alumni who have achieved distinction through leadership and excellence in their field, and honors those who have demonstrated exemplary service to their profession or community.

Christoph Stein (faculty, anesthesiology and critical care medicine, 1992–97) is co-founder and chief scientific officer of pHarm Therapeutics Inc., a biopharmaceutical company focused on developing novel pain medication based on pH-dependent activation of G-protein-coupled receptors.

Brian Krabak (HS, internal medicine, 1993–94; faculty, 1998–2007) was the team physician for USA Swimming at the Paris 2024 Olympics. He served in a similar role with USA Swimming at the 2019 World University Games and the 2022 and 2023 World Championships. 

David Newman-Toker (BSPH 2007; PGF, neurology, 2000–02; PGF, 2007–10; faculty, neurology, 2016–present) was awarded the 2024 Hallpike-Nylén prize by the Bárány Society, the leading international society focused on vestibular research. The Hallpike-Nylén prize is given to recognize the recipient’s achievements and contributions to clinical research related to dizziness, vertigo and balance disorders.

Dean Dalili (PGF, medicine, 2002–05; faculty 2007–09) has been named chief medical officer for DeepScribe, a leader in ambient artificial intelligence (AI) documentation for health care. He will be instrumental in guiding the company’s clinical strategy, advancing its enterprise-grade AI and fostering partnerships with health care organizations to drive widespread adoption of DeepScribe’s industry-leading technology.

Yuri Agrawal (HS, otolaryngology–head and neck surgery, 2005–10; faculty, otolaryngology–head and neck surgery, 2012–present) has been named chair of the Department of Otolaryngology – Head and Neck Surgery at the University of Colorado. She was formerly a professor of otology, neurotology and skull base surgery in the Department of Otolaryngology–Head and Neck Surgery at the school of medicine and an attending physician at The Johns Hopkins Hospital.

Justin Turner (HS, otolaryngology–head and neck surgery, 2006–11) has been named chair of the Department of Otolaryngology in the University of Alabama Marnix E. Heersink School of Medicine.